Back
Benchtop DNA Synthesis Devices: Capabilities, Biosecurity Implications, and Governance
webCredibility Rating
4/5
High(4)High quality. Established institution or organization with editorial oversight and accountability.
Rating inherited from publication venue: Nuclear Threat Initiative
Relevant to AI safety discussions around dual-use technology governance and the challenge of maintaining safety norms as powerful tools become more accessible; offers a biotech parallel to AI proliferation governance debates.
Metadata
Importance: 62/100organizational reportanalysis
Summary
This NTI report examines how emerging benchtop DNA synthesis devices threaten to decentralize DNA production, potentially circumventing existing biosecurity screening protocols maintained by centralized providers. It analyzes device capabilities, biosecurity risks from distributed access, and governance frameworks needed to maintain safety as the technology proliferates into individual laboratories.
Key Points
- •Centralized DNA synthesis providers currently screen orders to prevent synthesis of harmful sequences, but benchtop devices could bypass these safeguards.
- •Benchtop DNA synthesis machines enable labs to 'print' DNA on-site, shifting production from centralized to distributed models.
- •Decentralized DNA synthesis raises biosecurity risks including potential misuse for engineering dangerous pathogens without institutional oversight.
- •The report recommends governance approaches to extend biosecurity norms and screening requirements to benchtop device users and manufacturers.
- •This technology democratizes access to synthetic biology tools, creating dual-use risks analogous to other emerging biotechnologies.
Cited by 1 page
| Page | Type | Quality |
|---|---|---|
| Bioweapons Risk | Risk | 91.0 |
Cached Content Preview
HTTP 200Fetched Apr 7, 20267 KB
Benchtop DNA Synthesis Devices: Capabilities, Biosecurity Implications, and Governance
Close
Report
May 10, 2023
Benchtop DNA Synthesis Devices: Capabilities, Biosecurity Implications, and Governance
Share
-->
Twitter
Facebook
Linkedin
Email
Benchtop DNA Synthesis Devices: Capabilities, Biosecurity Implications, and Governance
Twitter
Facebook
Linkedin
Email
m">
Sarah R. Carter, Ph.D
Principal, Science Policy Consulting
Jaime M. Yassif, PhD
Senior Advisor
Chris Isaac
Links & Downloads
Download the Report
Download the Executive Summary
Synthetic DNA is used by bioscience laboratories around the world and plays a fundamental role in a wide range of science and biotechnology advances. DNA synthesis technology “prints” DNA and enables researchers to study and engineer biological systems to better understand how they work. It is also essential for a wide range of biotechnology advances, from agricultural products and pharmaceuticals to advanced fuels and other biomanufacturing applications.
Currently, nearly all synthetic DNA is produced by centralized providers who screen their customers and orders to help ensure that DNA with a potentially harmful sequence is not sold to customers without a legitimate use for it. However, a new generation of benchtop DNA synthesis devices—machines designed to be used on any lab workbench—will soon enable users to more easily print DNA in their own labs. This emerging technology has the potential to disrupt the centralized synthesis market and its associated biosecurity practices by driving DNA acquisition toward a more distributed model. The greater ease of access to synthetic DNA resulting from these new, more widely available benchtop devices—combined with scientific advances in our understanding of pathogens and insufficient oversight—may also empower malicious actors by making it easier to obtain the building blocks of potentially dangerous biological agents.
This report, Benchtop DNA Synthesis Devices: Capabilities, Biosecurity Implications, and Governance , draws on more than 30 interviews with experts from benchtop DNA synthesis companies, the broader biotechnology industry, the biosecurity and bioscience research communities, and other sectors. The report addresses the following key questions:
What is the current status of benchtop DNA synthesis device capabilities, and how will these capabilities evolve over the next 5–10 years?
What are the biosecurity implications of these developments?
What tools and oversight mechanisms can most effectively mitigate biosecurity risks?
The report outlines detailed findings to answer each
... (truncated, 7 KB total)Resource ID:
281a855768b94705 | Stable ID: MDBkMGQzNG